• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT RX ACCULINK CAROTID STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT RX ACCULINK CAROTID STENT SYSTEM Back to Search Results
Catalog Number 1011344-40
Device Problems Migration or Expulsion of Device (1395); Device Damaged by Another Device (2915)
Patient Problem Foreign Body In Patient (2687)
Event Date 02/06/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation however; it is likely that device interactions during procedure contributed the reported stent migration.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents reported from this lot.The investigation determined the reported difficulties and treatment appears related to operational circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The emboshield device referenced in b5 and d11 is filed under a separate medwatch report.
 
Event Description
It was reported that the procedure was to treat a lesion in the heavily tortuous, heavily calcified internal carotid artery.After placement of the emboshield nav 6 embolic protection system, a 7-10 x 40 mm acculink self-expanding stent system (sess) was advanced without resistance to the lesion; and was successfully deployed.The stent was post-dilated with an unspecified balloon dilatation catheter.During removal of the nav 6 device; when pulling the barewire and the filter resistance was felt with the anatomy, and the deployed acculink stent was pulled into the carotid common artery.No further treatment was performed in the internal carotid artery.The acculink stent remains well apposed in healthy tissue in the common carotid artery.There was no adverse patient sequela and no clinically significant delay during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX ACCULINK CAROTID STENT SYSTEM
Type of Device
CAROTID STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6336276
MDR Text Key67597570
Report Number2024168-2017-01260
Device Sequence Number1
Product Code NIM
UDI-Device Identifier08717648076398
UDI-Public(01)08717648076398(17)180930(10)6100361
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 02/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2018
Device Catalogue Number1011344-40
Device Lot Number6100361
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
EMBOLIC PROTECTION: EMBOSHIELD NAV6
Patient Outcome(s) Other;
Patient Age72 YR
Patient Weight102
-
-